Orthopedic Implants Market to Reach USD 26.47 Billion by 2029, Driven by Aging Population and Advancements in Implant Technology

The global Orthopedic Implants Market is projected to grow from USD 20.94 billion in 2024 to USD 26.47 billion by 2029, registering a CAGR of 4.8% during the forecast period. According to MarketsandMarkets™, the market is experiencing steady growth due to the increasing prevalence of orthopedic disorders, technological advancements in implant materials and surgical procedures, expanding healthcare infrastructure, and the growing geriatric population worldwide.

Orthopedic implants have become an integral part of modern healthcare, helping restore mobility, reduce pain, and improve the quality of life for millions of patients suffering from joint degeneration, fractures, osteoporosis, and sports-related injuries. Increasing awareness of orthopedic treatments, along with rising numbers of joint replacement surgeries, continues to support long-term market expansion.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5230937

Market Growth Drivers

Several factors are contributing to the growth of the Orthopedic Implants Market:

  • Rising prevalence of osteoarthritis, osteoporosis, and traumatic fractures.
  • Growing elderly population requiring joint replacement procedures.
  • Continuous technological advancements in implant materials and surgical techniques.
  • Increasing demand for minimally invasive orthopedic surgeries.
  • Rising healthcare expenditure across developed and emerging economies.
  • Expanding access to advanced orthopedic care and rehabilitation services.

As life expectancy increases globally, the demand for durable and high-performance orthopedic implants is expected to continue growing.

Knee Implants Continue to Lead the Market

Based on type, the orthopedic implants market is segmented into:

  • Knee Implants
  • Hip Implants
  • Shoulder Implants
  • Elbow Implants
  • Foot & Ankle Implants
  • Wrist Implants
  • Other Orthopedic Implants

The knee implants segment accounted for the largest market share in 2023.

Growth is primarily driven by:

  • Increasing prevalence of knee osteoarthritis.
  • Rising number of total knee replacement procedures.
  • Growing demand for revision knee surgeries.
  • Improved implant longevity and surgical outcomes.

According to healthcare statistics, more than 70,000 knee replacement surgeries are performed annually in England and Wales, while the American Academy of Orthopaedic Surgeons (AAOS) reported a 23% increase in primary and revision hip and knee arthroplasty procedures between 2012 and 2022, highlighting the growing demand for orthopedic implants.

Metal and Metal Alloys Remain the Preferred Implant Material

Based on material, the market is segmented into:

  • Metal and Metal Alloys
  • Ceramics
  • Polymers
  • Hybrid Implants

The metal and metal alloys segment held a significant market share in 2023.

These materials continue to dominate because they offer:

  • Excellent mechanical strength.
  • Superior wear resistance.
  • Long-term durability.
  • High biocompatibility.
  • Compatibility with diagnostic imaging such as X-rays and CT scans.

Titanium alloys, stainless steel, and cobalt-chromium alloys remain the most commonly used materials for orthopedic implant manufacturing.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=5230937

Hospitals & Surgical Centers Dominate End Users

Based on end user, the market includes:

  • Hospitals & Surgical Centers
  • Ambulatory & Trauma Care Centers

The hospitals and surgical centers segment accounted for the largest share of the market in 2023.

Several factors support this dominance:

  • Availability of advanced orthopedic surgical equipment.
  • Increasing investments in healthcare infrastructure.
  • Growing number of orthopedic specialists.
  • Rising volume of joint replacement procedures.
  • Expanding government and private funding for healthcare facilities.

Hospitals continue to be the preferred setting for complex orthopedic surgeries requiring specialized surgical teams and postoperative care.

North America Leads the Global Orthopedic Implants Market

The market is geographically segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America accounted for the largest market share in 2023.

Regional growth is supported by:

  • Presence of leading orthopedic implant manufacturers.
  • High healthcare spending.
  • Increasing incidence of fractures and degenerative joint diseases.
  • Growing medical tourism.
  • Favorable reimbursement policies.
  • Strong adoption of advanced surgical technologies.

Europe remains another significant market due to its aging population and established healthcare systems, while Asia Pacific is expected to witness the fastest growth owing to expanding healthcare infrastructure, rising disposable income, and increasing awareness of orthopedic treatments.

Competitive Landscape

The Orthopedic Implants Market is highly consolidated, with several multinational medical device companies driving innovation through product development, strategic acquisitions, partnerships, and geographic expansion.

Stryker Corporation

Stryker is one of the global leaders in orthopedic implants, offering an extensive portfolio through its Orthopaedics & Spine division.

The company operates in more than 75 countries across:

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Stryker continues investing in robotic-assisted surgery, digital orthopedics, and next-generation implant technologies to strengthen its leadership position.

Zimmer Biomet Holdings, Inc.

Zimmer Biomet is a leading global medical technology company specializing in orthopedic reconstruction and musculoskeletal healthcare.

Its orthopedic implant portfolio includes:

  • Knee Systems
  • Hip Systems
  • S.E.T. (Sports Medicine, Extremities & Trauma)

The company maintains a strong international distribution network across Europe, Asia Pacific, the Middle East, and other global markets while continuously investing in research and development to expand its product offerings.

Johnson & Johnson MedTech

Johnson & Johnson MedTech remains a major player in the orthopedic implants market through continuous innovation and strategic collaborations.

The company develops orthopedic implants designed to improve patient outcomes and supports innovation through partnerships with emerging medical technology companies. Its collaboration with CrossRoads Extremity Systems reflects its commitment to advancing orthopedic care and expanding treatment options for patients worldwide.

Key Companies Operating in the Market

Major companies shaping the Orthopedic Implants Market include:

  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson & Johnson MedTech
  • Smith+Nephew
  • B. Braun

These organizations continue focusing on innovation, acquisitions, robotic-assisted surgery, digital healthcare integration, and product portfolio expansion to maintain their competitive advantage.

Future Outlook

The Orthopedic Implants Market is expected to experience steady growth over the coming years as healthcare systems increasingly prioritize mobility restoration, active aging, and improved quality of life. Advances in biomaterials, 3D printing, robotic-assisted orthopedic surgery, smart implants, and personalized treatment planning are expected to transform orthopedic care.

Growing demand for minimally invasive procedures, rising awareness of joint replacement benefits, and continued investments in orthopedic research will create new opportunities for manufacturers, healthcare providers, and patients worldwide.

Inquire Before Buying:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=5230937

Share this post:

Recent Posts

Comments are closed.